BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6259089)

  • 1. [Results of curative, distal resection of stomach neoplasms].
    Baumann C; Uhlschmid G; Hollinger A; Largiadèr F
    Helv Chir Acta; 1980 Dec; 47(5):555-50. PubMed ID: 6259089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer: a critical analysis of surgical treatment and long term survival.
    Sarker SK; Sinha VK; Chaudhry R; Maudar KK
    J Indian Med Assoc; 1992 Mar; 90(3):61-4. PubMed ID: 1634787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma of the stomach. Resectability and survival rates in 408 operated patients (author's transl)].
    Moreaux J; Montupet P
    Nouv Presse Med; 1981 Oct; 10(38):3133-6. PubMed ID: 7290975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
    Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
    Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection.
    Deng JY; Liang H; Sun D; Zhan HJ; Wang XN
    J Surg Oncol; 2008 Oct; 98(5):343-8. PubMed ID: 18668672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of curative gastrectomy for carcinoma of the distal third of the stomach.
    Wu CW; Hsieh MC; Lo SS; Lui WY; P'eng FK
    J Am Coll Surg; 1996 Sep; 183(3):201-7. PubMed ID: 8784312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of long-term survivors of scirrhous gastric cancer.
    Takahashi I; Matsusaka T; Onohara T; Nishizaki T; Ishikawa T; Tashiro H; Wakasugi K; Kume K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2000; 47(35):1485-8. PubMed ID: 11100383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].
    Schafmayer C; Jürgens G; Jürgens I; Klomp HJ; Fändrich F; Kahlke V
    Zentralbl Chir; 2007 Dec; 132(6):515-22. PubMed ID: 18098079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The kinetics of the survival rate of patients following radical surgery for stomach cancer].
    Korman DB; Kravets BB; Evseenko LS; Emanuel' NM
    Vopr Onkol; 1970; 16(1):46-52. PubMed ID: 4314019
    [No Abstract]   [Full Text] [Related]  

  • 16. Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2001; 48(41):1509-12. PubMed ID: 11677997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival rate for gastric carcinoma in relation to tumor site and stage (author's transl)].
    Husemann B
    MMW Munch Med Wochenschr; 1980 Aug; 122(32-33):1123-6. PubMed ID: 6258059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radical treatment of gastric carcinoma.
    Ranzato R; Fiamingo P; Veroux M; D'Amico DF
    Minerva Chir; 2004 Oct; 59(5):471-7. PubMed ID: 15494674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival following microscopical radical resection of stomach cancer].
    Brems-Dalgaard E; Clausen HV
    Ugeskr Laeger; 1995 Feb; 157(9):1196-8. PubMed ID: 7701666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.